These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26018603)

  • 1. Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells.
    González H; Contreras F; Pacheco R
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):561-75. PubMed ID: 26018603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases.
    González H; Pacheco R
    J Neuroinflammation; 2014 Dec; 11():201. PubMed ID: 25441979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine Receptor D3 Expression Is Altered in CD4
    Elgueta D; Contreras F; Prado C; Montoya A; Ugalde V; Chovar O; Villagra R; Henríquez C; Abellanas MA; Aymerich MS; Franco R; Pacheco R
    Front Immunol; 2019; 10():981. PubMed ID: 31118938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
    González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
    J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease: Autoimmunity and neuroinflammation.
    De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
    Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease.
    Kustrimovic N; Marino F; Cosentino M
    Curr Med Chem; 2019; 26(20):3719-3753. PubMed ID: 30306855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
    Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM
    Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.
    Garretti F; Agalliu D; Lindestam Arlehamn CS; Sette A; Sulzer D
    Front Immunol; 2019; 10():303. PubMed ID: 30858851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia and Parkinson's disease: footprints to pathology.
    Lazdon E; Stolero N; Frenkel D
    J Neural Transm (Vienna); 2020 Feb; 127(2):149-158. PubMed ID: 32016606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases.
    Sommer A; Winner B; Prots I
    Mol Neurodegener; 2017 Oct; 12(1):78. PubMed ID: 29078813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The major histocompatibility complex participates in Parkinson's disease.
    Gu R; Pan J; Awan MUN; Sun X; Yan F; Bai L; Bai J
    Pharmacol Res; 2024 May; 203():107168. PubMed ID: 38583689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation and regulation of CD4
    Sun X; Gu R; Bai J
    Cell Mol Life Sci; 2024 Aug; 81(1):352. PubMed ID: 39153043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of T cells in the pathogenesis of Parkinson's disease.
    Chen Z; Chen S; Liu J
    Prog Neurobiol; 2018 Oct; 169():1-23. PubMed ID: 30114440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.
    Qian L; Flood PM; Hong JS
    J Neural Transm (Vienna); 2010 Aug; 117(8):971-9. PubMed ID: 20571837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.
    Gelders G; Baekelandt V; Van der Perren A
    J Immunol Res; 2018; 2018():4784268. PubMed ID: 29850629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Parkinson's disease an autoimmune disorder of endogenous vasoactive neuropeptides?
    Staines DR
    Med Hypotheses; 2007; 69(6):1208-11. PubMed ID: 17562359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia in Parkinson's Disease.
    Ho MS
    Adv Exp Med Biol; 2019; 1175():335-353. PubMed ID: 31583594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies.
    Rocha NP; de Miranda AS; Teixeira AL
    Biomed Res Int; 2015; 2015():628192. PubMed ID: 26295044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.